AI-Generated Drugs to Reach Market by 2030, Says Insilico CEO

The first drugs conceived entirely by artificial intelligence will likely be commercially available around the end of the decade, according to the leader of an AI drug discovery startup.

“I would be surprised if we don’t see it over the next five to six years,” Alex Zhavoronkov, chief executive officer of Insilico Medicine, said in an interview with Bloomberg Television. “I hope we will be the first ones – we have more than 40 programs internally – but you never know.”